Printer Friendly Version View printer-friendly version
<< Back
Natera Announces Fourth Quarter and Fiscal 2020 Earnings Conference Call

SAN CARLOS, Calif., Feb. 18, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its fourth quarter and year ended December 31, 2020, after the market close on February 25, 2021. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.

Earnings Conference Call Information:

Event:

Natera's Fourth Quarter and Year-End 2020 Financial Results



Date:

Thursday, February 25, 2021 



Time: 

1:30 p.m. PT (4:30 p.m. ET)



Live Dial-In:

(877) 823-0171, Domestic
(617) 500-6932, International



Password: 

8877495



Webcast:

https://edge.media-server.com/mmc/p/ksr9bar5

A webcast replay will be available at investor.natera.com.

About Natera

Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn.

Contacts

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Paul Greenland, VP of Corporate Marketing, Natera, Inc., pr@natera.com 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/natera-announces-fourth-quarter-and-fiscal-2020-earnings-conference-call-301230669.html

SOURCE Natera, Inc.

Footer disclaimer

Footer disclaimer

© Natera 2021. All Rights Reserved. The tests described on this site were developed by Natera, Inc. a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). The tests have not been cleared or approved by the U.S. Food and Drug Administration (FDA). Although FDA does not currently clear or approve laboratory-developed tests in the U.S., certification of the laboratory is required under CLIA to ensure the quality and validity of the tests.